2030년까지의 유럽 항체 발견 시장 전망 - 지역 분석 - 항체 유형(단일클론 항체, 다클론 항체 및 기타), 자연(인간 및 인간화, 키메라 및 쥐), 서비스(파지 디스플레이, 하이브리도마, 형질전환 동물, 단일 세포 및 효모 디스플레이) 및 최종 사용자(제약 및 생명공학 회사, 연구소 및 기타)
암 발병률 증가로 유럽 항체 발견 시장이 성장
2020년에 발표된 Global Cancer Observatory(GLOBOCAN) 추정치에 따르면 전 세계적으로 1,930만 건의 암 사례가 발생했습니다. 2030년 1월까지 암 생존자 인구는 2,210만 명에 도달할 것으로 추산되며 이는 주로 인구 고령화와 관련이 있을 수 있습니다. 폐암, 유방암, 대장암, 전립선암, 유방암은 가장 흔하게 보고되는 암 유형 중 일부입니다. 암 발병률 증가로 전 세계적으로 우려가 제기되었습니다. 아래는 2020년 전 세계에서 보고된 흔한 암 사례 목록입니다.
2020년 전 세계 신규 암 사례
Sr. 아니요.
암 유형
사례 수(백만)
1
위
1.09
2
피부(비흑색종)
1.2
3
전립선
1.41
4
대장 및 직장
1.93
5
폐
2.21
6
유방
2.26
출처: 세계보건기구, 2020년 2월
암은 이제 건강에 해로운 식습관을 가진 사람들과 신체 활동을 많이 하지 않는 사람들에게 흔히 나타나는 생활 방식 질환입니다. 술과 담배를 자주 마시면 암 발병 위험이 커집니다. 저소득 및 중소득 국가의 만성 감염병은 암 위험 요소를 더욱 악화시킬 수 있습니다. 암 발병률의 급증은 혁신적인 암 치료법의 필요성을 나타냅니다. 단일클론 항체는 면역 체계가 암 세포 활동을 억제하고 암 세포를 제거하는 자연적 능력을 향상시키는 유망한 종류의 표적 항암제를 나타냅니다. 항체-약물 접합체(ADC)도 암 치료에서 유망한 결과를 보였습니다. 또한 현대 생명공학의 발전으로 연구자와 회사는 잘 설계된 새로운 항체를 제공하여 다양한 유형의 암을 성공적으로 치료할 수 있는 길을 열었습니다. 따라서 다양한 유형의 암 발병률이 급증함에 따라 항체 발견 시장 성장이 촉진됩니다.
유럽 항체 발견 시장 개요
유럽 항체 발견 시장은 독일, 영국, 프랑스, 이탈리아, 스페인 및 기타 유럽으로 세분화됩니다. 이 지역은 글로벌 시장에서 상당한 점유율을 차지합니다. R&D 응용 프로그램, 암 치료 및 면역 질환 관리에서 모노클로날 항체의 사용이 급증함에 따라 향후 몇 년 동안 강력한 성장률을 기록할 것으로 예상됩니다. 또한 환자 데이터 관리 시스템에 대한 필요성 증가, 만성 질환의 유병률 및 항체 서비스 구현을 위한 정부 이니셔티브는 프랑스, 이탈리아 및 스페인과 같은 국가의 항체 발견 시장에 성장 기회를 제공할 것으로 예상됩니다.
2030년까지의 유럽 항체 발견 시장 수익 및 예측(10억 달러)
유럽 항체 발견 시장 세분화
유럽 항체 발견 시장은 항체 유형, 특성, 서비스, 최종 사용자 및 국가로 분류됩니다.
항체 유형을 기준으로 유럽 항체 발견 시장은 모노클로날 항체, 폴리클로날 항체 및 기타로 세분화됩니다. 단일클론 항체 세그먼트는 2022년에 유럽에서 가장 큰 항체 발견 시장 점유율을 차지했습니다.
자연 측면에서 유럽 항체 발견 시장은 인간 및 인간화, 키메라 및 쥐로 세분화됩니다. 인간 및 인간화 세그먼트는 2022년에 가장 큰 유럽 항체 발견 시장 점유율을 차지했습니다.
서비스별로 유럽 항체 발견 시장은 파지 디스플레이, 하이브리도마, 형질전환 동물, 단일 세포 및 효모 디스플레이로 구분됩니다. 파지 디스플레이 세그먼트는 2022년에 가장 큰 유럽 항체 발견 시장 점유율을 차지했습니다.
최종 사용자 기준으로 유럽 항체 발견 시장은 제약 및 생명 공학 회사, 연구실 및 기타로 분류됩니다. 제약 및 생명 공학 회사 세그먼트는 2022년에 가장 큰 유럽 항체 발견 시장 점유율을 차지했습니다.
국가 기준으로 유럽 항체 발견 시장은 독일, 영국, 프랑스, 이탈리아, 스페인 및 유럽의 나머지 지역으로 분류됩니다. 독일은 2022년 유럽 항체 발견 시장 점유율에서 우위를 차지했습니다.
Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, Biocytogen Pharmaceuticals Beijing Co Ltd.는 유럽 항체 발견 시장에서 활동하는 주요 기업 중 일부입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antibody Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market - Europe Market Analysis
5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. Europe Antibody Discovery Market Analysis - by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Antibody Discovery Market Analysis - by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Antibody Discovery Market Analysis - by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Antibody Discovery Market Analysis - by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Antibody Discovery Market - Country Analysis
10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
10.1.1.1 UK
10.1.1.1.1 Overview
10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
10.1.1.3 France
10.1.1.3.1 Overview
10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Italy
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
10.1.1.5 Spain
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Europe
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Aragen Life Sciences Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Europe Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Europe Antibody Discovery Market Segmentation, by Country
Figure 2. Europe Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- Creative Biolabs Inc
- Evotec SE
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.